Red cell distribution width is associated with albuminuria in adults with familial Mediterranean fever  by Uslu, Ali Ugur et al.
Kaohsiung Journal of Medical Sciences (2016) 32, 216e220Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comORIGINAL ARTICLERed cell distribution width is associated with
albuminuria in adults with familial Mediterranean
fever
Ali Ugur Uslu a,*, Ozlem Yonem b, Bahattin Aydin c, Tunahan Uncu d,
Dogan Seven d, Sevket Balta e, Emre Cicekli da Department of Internal Medicine, Eskisehir Military Hospital, Eskisehir, Turkey
b Department of Gastroenterology, Cumhuriyet University Faculty of Medicine, Sivas, Turkey
c Department of Internal Medicine, Etimesgut Military Hospital, Ankara, Turkey
d Department of Internal Medicine, Cumhuriyet University Faculty of Medicine, Sivas,
Turkey
e Department of Cardiology, Gulhane Medical Academy Ankara, TurkeyReceived 15 February 2016; accepted 30 March 2016
Available online 24 April 2016KEYWORDS
Albuminuria;
Familial
Mediterranean fever;
Microalbuminuria;
Red cell distribution
width;
Systemic
inflammationConflicts of interest: All authors d
* Corresponding author. Eskisehir Mil
Eskisehir, Turkey.
E-mail address: draliugur@hotmail
http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2016, Kaohsiu
CC BY-NC-ND license (http://creativAbstract Systematic inflammation, enhanced oxidative stress, and endothelial dysfunction
are important for evolution and progression of renal damage, and they cause an increase in
red cell distribution width (RDW). Familial Mediterranean fever (FMF) patients who are in the
attack-free period and its relation with albuminuria and performance on assessment of microal-
buminuria. One hundred and seventy-seven patientswho had been diagnosed in accordancewith
Tel-hoshmer criteria and were in the attack-free period, and 143 age- and sex-matched healthy
individuals were enrolled in our study. RDW values of FMF patients were higher compared with
those of the controls (13.85  1.07 and 13.15  0.91, respectively; p < 0.0001). RDW values
of FMF patients with microalbuminuria were higher compared with those of FMF patients with
normoalbuminuria and the control group (pZ 0.002 and p < 0.0001, respectively). RDW values
of FMF patients with normoalbuminuria were higher compared with those of the control group
(p < 0.0001). We have showed RDW levels are positively correlated with albuminuria
(rZ 0.185, pZ 0.014). When assessing microalbuminuria with RDW in the patients, a cutoff
value of 13.85 with sensitivity of 60%, specificity of 62%, and p Z 0.002 (area under curve:
0.651, 95% confidence interval 0.563e0.738), was observed according to receiver-operatingeclare no conflicts of interest.
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RDW and albuminuria in FMF patients 217characteristic curve analysis. Among the various variables associated with albuminuria in multi-
variate logistic regression analyses, RDW remained an independent predictor of albuminuria
(95% confidence interval 0.479e0.942, pZ 0.021). RDW may be associated with albuminuria
in FMF patients and it can be a predictor of microalbuminuria.
Copyright ª 2016, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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Familial Mediterranean Fever (FMF) is the most common
autosomal recessively inherited autoinflammatory disorder.
Attacks characterized by fever, inflammation in the syno-
vial and serosal membranes, and skin involvement are
observed in most of the patients [1,2]. Attacks usually
reduce within 12e72 hours, and the attack-free period may
be completely asymptomatic. The pathogenesis of the
disease is the mutation of Mediterranean fever gene, which
encodes the pyrin/marenostrin protein in the 16th chro-
mosome. As a result of this mutation of the gene, control of
the inflammatory process fails [3,4].
Secondary amyloidosis symptoms can be observed
directly in some patients without any symptoms and find-
ings. That is prognostic and the most feared complication in
the course of the disease [5]. Early stage is completely
asymptomatic in this condition, during which renal
involvement can be observed frequently and can be pre-
sented as microalbuminuria as well as end-stage renal
impairment symptoms [5e7]. Microalbuminuria can be used
as an indicator of early renal damage in the process of
amyloidosis and/or renal damage development in the
management of renal pathologies [8,9].
Red cell distribution width (RDW) is a simple and inex-
pensive marker used very often in clinical practice; it is
used to assess the changes of red blood cell size in com-
plete blood count. RDW is often used as a guide for dif-
ferential diagnosis with respect to thalassemia trait in
anemia [10,11]. Additionally, existence of systemic
inflammation may cause an increase in RDW. There are
studies related to RDW in FMF patients, and it was reported
that RDW can be used as a marker of subclinical inflam-
mation [12,13].
The goal of this study is to examine the changes in RDW,
which is connected to systemic inflammation in FMF pa-
tients who are in the attack-free period, and its relation
with albuminuria and performance regarding assessment of
microalbuminuria.Methods
One hundred and seventy-seven patients, who had been
diagnosed in accordance with Tel-hoshmer criteria [14] and
were in the attack-free period, and 143 age- and sex-
matched healthy individuals were enrolled in our study.
Files and archives of the patient group and healthy in-
dividuals were examined. Complete blood count, inflam-
matory markers, urinary albumin levels, and estimatedglomerular filtration rate of the patient group, and com-
plete blood count and inflammatory markers of the control
group were registered. Laboratory parameters of both
study groups were analyzed by the same analyzer. Kidney
function was estimated by glomerular filtration rate using
the abbreviated formula developed and validated in the
Modification of Diet in Renal Disease study. Albuminuria was
calculated using the spot urine albumin/creatinine ratio.
Patients were divided into two groups according to their
daily albuminuria. Patients with 0e29 mg/d albuminuria
were included in the normoalbuminuria patient group and
those with 30e299 mg/d albuminuria were included in the
microalbuminuria patient group. Patients with anemia, B12
and folic acid deficiency, thyroid dysfunction, diabetes
mellitus, hypertension, cardiovascular disease, chronic
obstructive respiratory disease, acute and/or chronic
infection, and a smoking history were excluded from the
study. Patients with  300 mg/d albuminuria were also
excluded from the study because of the small patient
group.
The complete blood count was performed using the
same analyzer, Mindray BC-6800 (Shenzhen Mindray
Bio-Medical Electronics Co. Ltd., Shenzhen, China), which
is routinely checked every month in the central laboratory
of our institution. Standard tubes with a constant amount
of EDTA were used.
Statistical analysis
All statistical analyses were performed with SPSS version
15.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics
were presented as arithmetic mean  standard deviation.
The significance of the mean differences between groups
was assessed by Student t test and one-way analysis of
variance (ANOVA). Differences were assessed by Chi-square
test for categorical variables. Relationships between vari-
ables were tested using Spearman’s correlation analysis.
Receiver-operating characteristic curve graphics were used
in the comparison of sensitivity and specificity. Various
variables associated with albuminuria in multivariate lo-
gistic regression analyses were assessed. A p value < 0.05
was regarded as significant.Results
No age and sex difference were observed between FMF
patients and control group (Table 1). RDW values of FMF
patients were 13.85  1.07 and those of the control group
13.15  0.91; RDW values of the patients were higher
Table 1 Baseline clinical laboratory and demographic
characteristics of patients and controls.
FMF patients
(n Z 177)
Controls
(n Z 143)
p
Age (y) 30.9  11.6 33.0  11.1 0.106
Male/female 62 (35)/115
(65)
62 (43.4)/81
(56.6)
0.129
ESR (mm/h) 9.27  12.71 7.76  2.75 0.332
CRP, mg/L 2.93  2.08 2.31  1.67 0.132
Leukocyte
(109/L)
6.68  2.64 6.93  1.44 0.284
Platelet
(109/L)
273.29  67.44 261.67  54.88 0.090
Hemoglobin
(g/dL)
13.93  1.30 14.39  1.37 0.003
MCV (fL) 83.33  4.83 85.73  4.33 0.016
RDW (%) 13.85  1.07 13.15  0.91 <0.0001
Data are presented as n (%) or mean  standard deviation.
CRPZ C-reactive protein; ESR Z erythrocyte sedimentation
rate; FMF Z familial Mediterranean fever; MCV Z mean
corpuscular volume; RDW Z red cell distribution width.
Table 2 Baseline characteristics of patients with FMF.
FMF patients (n Z 177)
Age at diagnosis (y) 20.8  12.4
Duration of illness (y) 9.1  10.6
Dose of colchicine (mg/d) 1.27  0.49
Blood urea nitrogen (mg/dL) 11.28  4.75
Serum creatinine (mg/dL) 0.70  0.17
Serum albumin (mg/dL) 4.72  3.68
Albuminuria (mg/d) 32.84  48.09
eGFR (mL/min/1.73 m2) 120.14  40.42
Data are presented as mean  standard deviation.
eGFR Z estimated glomerular filtration rate; FMF Z familial
Mediterranean fever.
Table 3 Comparison between FMF patients with micro-
albuminuria and FMF patients with normoalbuminuria in
terms of clinical laboratory and demographic
characteristics.
FMF patients with
microalbuminuria
(n Z 51)
FMF patients with
normoalbuminuria
(n Z 126)
p
Age (y) 32.2  11.5 30.3  11.6 0.324
Male/female 18 (35.3)/33
(64.7)
44 (34.9)/82
(65.1)
0.547
Leukocyte
(109/L)
5.23  3.44 7.27  1.96 <0.0001
Platelet
(109/L)
266.59  72.21 276.00  65.52 0.422
Hemoglobin
(g/dL)
13.52  1.34 14.10  1.25 0.010
CRP (mg/L) 3.06  2.29 2.87  1.99 0.723
Albuminuria
(mg/d)
84.05  65.16 12.11  7.43 <0.0001
RDW (%) 14.27  1.12 13.68  1.01 0.002
Data are presented as n (%) or mean  standard deviation.
CRPZ C-reactive protein; FMFZ familial Mediterranean fever;
RDW Z red cell distribution width.
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laboratory characteristics of the patients and control group
are shown in Table 1. Main clinical and some laboratory
characteristics of the patients are shown in Table 2.
No age and sex difference were observed between the
patients with microalbuminuria and those with normoalbu-
minuria (Table 3). RDW values were 14.27  1.12 for FMF
patients with microalbuminuria, 13.68  1.01 for FMF pa-
tients with normoalbuminuria, and 13.15  0.91 for the
control group. RDW values of FMF patients with micro-
albuminuria were higher compared with those of FMF pa-
tients with normoalbuminuria and the control group
(pZ 0.002 and p < 0.0001, respectively). RDW values of FMF
patients with normoalbuminuria were higher compared with
those of the control group (p < 0.0001). The baseline labo-
ratory characteristics of FMF patients with microalbuminuria
and those with normoalbuminuria are shown in Table 3.
When albuminuria of FMF patients was assessed, no
relation with the age, sex, duration of disease, and
administered dose of colchicine was observed. No relation
was detected between albuminuria and serum ureanitrogen, creatinine, and creatinine clearance calculated
with the modification of diet in renal disease method.
There was no relation between albuminuria of the patients
and inflammatory markers such as hemoglobin, mean
corpuscular volume, hematocrit, platelet, leukocyte,
Creactive protein, and erythrocyte sedimentation rate.
Rather, albuminuria is positively correlated with RDW
(r Z 0.185, p Z 0.014; Table 4).
When assessing microalbuminuria with RDW in the pa-
tients, a cutoff value of 13.85 with sensitivity 60%, speci-
ficity 62%, and p Z 0.002 (area under curve, 0.651; 95%
confidence interval 0.563e0.738) was observed according
to receiver-operating characteristic curve analysis
(Figure 1). Among the various variables associated with
albuminuria in multivariate logistic regression analyses,
RDW remained an independent predictor of albuminuria
(95% confidence interval 0.479e0.942, pZ 0.021; Table 5).
Discussion
In this study, the relationship between RDW and albumin-
uria in FMF patients was assessed. It was observed that RDW
in FMF patients was higher compared with that in the
control group. It was detected that RDW values of the pa-
tients with microalbuminuria were higher compared with
those of the patients with normoalbuminuria, and a positive
correlation between RDW and albuminuria was observed.
RDW causes changes in many factors affecting the
erythroid series in the bone marrow. Increase in RDW can
be observed secondary to immunohemolysis, myelodys-
plastic syndrome, and chemotherapy in iron deficiency
anemia, megaloblastic anemia, and hemoglobinopathy
[15,16]. Additionally, the effect of the presence of systemic
inflammation on bone marrow and the heterogeneity of
erythrocytes may cause an increase in RDW. In studies on
Table 4 Correlation between RDW and other parameters
according to albuminuria.
r p
Age (y) 0.096 0.206
eGFR (mL/min/1.73 m2) 0.051 0.518
ESR (mm/h) 0.028 0.808
CRP (mg/L) 0.176 0.110
Leukocyte (109/L) 0.124 0.100
Platelet (109/L) 0.025 0.739
Hemoglobin (g/dL) 0.132 0.080
RDW (%) 0.185 0.014
CRPZ C-reactive protein; eGFR Z estimated glomerular
filtration rate; ESR Z erythrocyte sedimentation rate;
RDW Z red cell distribution width.
Figure 1. Receiver-operating characteristic curve of the red
cell distribution width for predicting microalbuminuria in FMF
patients. AUC Z area under curve; FMF Z familial Mediter-
ranean fever; RDW Z red cell distribution width.
Table 5 Effects of various variables on albuminuria in
multivariate logistic regression analyses.
Odds
ratio
95% confidence
interval
p
Age (y) 0.986 0.952e1.021 0.424
Gender 0.486 0.191e1.237 0.130
eGFR (mL/min/1.73 m2) 1.001 0.984e1.018 0.944
CRP (mg/L) 1.066 0.819e1.386 0.635
Hemoglobin (g/dL) 1.570 1.090e2.261 0.016
RDW (%) 0.672 0.479e0.942 0.021
CRPZ C-reactive protein; eGFR Z estimated glomerular
filtration rate; RDW Z red cell distribution width.
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systemic inflammation, which continued in the attack-free
period, may result in an increase in RDW [12e16].
As a result of the effects of systemic inflammation in
FMF patients, high levels of serum amyloid A protein were
produced in the liver in response to cytokines and this
inflammation puts at risk of developing complications like
anemia, splenomegaly, decreased bone mineral density,
cardiovascular diseases and life-threatening amyloid A
amyloidosis, among others [17]. While renal involvement is
frequently observed in amyloidosis, albuminuria is impor-
tant in diagnosis and follow-up [18]. There is no study
related to renal involvement and/or damage in FMF pa-
tients with RDW. The number of studies assessing renal
functions and/or renal damages with RDW is considerably
limited. There are studies on RDW in patients with chronic
kidney disease [19,20] and patients with albuminuria based
on hypertension [21] and diabetes mellitus [22].
Systematic inflammation, enhanced oxidative stress,
and endothelial dysfunction are important for evolution
and progression of renal damage, and they cause an in-
crease in RDW at the same time [23]. Afonso et al [19]
indicated that RDW has a positive correlation with albu-
minuria, and RDW values were high in patients with low
estimated glomerular filtration rate values in their study.
Lippi et al [20] reported that the RDW value increased,
while the estimated glomerular filtration rate value
decreased in their study. Li et al [21] reported, in their
study on hypertensive patients, that there is a positive
correlation between RDW and albuminuria. Zhang et al
[22], in their study on patients with newly diagnosed type 2
diabetes mellitus, reported that RDW values are higher in
patients with microalbuminuria compared with those in
patients with normoalbuminuria.
During the attack, inflammatory markers usually increase
in FMF patients. Studies have shown that systemic inflam-
mation continues during the attack-free period in patients
with FMF [17]. Furthermore, it was reported that cytokines
and serum amyloid A levels were high in the attack free
period. Presence of systematic inflammation, enhanced
oxidative stress, and a high level of serum amyloid A may
cause evolution and progression of renal damage and
development of amyloidosis [6,18,24]. At the same time, as
a result of the effects of cytokines on erythroid precursors,
production of erythropoietin, and the effects of enhanced
hepcidin levels on iron metabolism, an increase in RDW may
be observed [12,21,25]. O¨zer et al [13] showed that RDW
values were higher in patients with FMF during symptom-free
periods. They suggested that RDW could be a potential
subclinical inflammation marker in patients with FMF.
Based on the higher RDW values in FMF patients
compared with the control group, higher RDW values in FMF
patients with microalbuminuria compared with normoal-
buminuric patient group, the positive correlation between
RDW values and albuminuria in the patients, cutoff value of
13.85 with and sensitivity of 60% and specificity of 62% with
p Z 0.002 according to receiver-operating characteristic
curve analysis when assessing microalbuminuria with RDW
in FMF patients, we concluded that there may be changed
in RDW values related to systemic inflammation in FMF
patients and these changes may be associated with
albuminuria.
220 A.U. Uslu et al.Our study has some limitations. The most important
limitations are that patients with macroalbuminuria and/or
amyloidosis were not included in our study, and it is a
retrospective cross-sectional study. Another limitation of
this study is that we have not assessed the relation between
the albuminuria and RDW levels and the prognosis of FMF.
In conclusion, we suggest that RDW values may change
depending on systemic inflammation in FMF patients during
the attack-free period, RDW may be associated with albu-
minuria in FMF patients, and it can be a predictor of
microalbuminuria.
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